Differences in Presentation of SARS-CoV-2 Omicron Strain Variant BA.1–BA.5 Peptides by HLA Molecules

被引:0
|
作者
S. A. Nersisyan
M. Yu. Shkurnikov
A. P. Zhiyanov
V. O. Novosad
A. G. Tonevitsky
机构
[1] Laboratory of Microfluidic Technologies for Biomedicine,
[2] Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry,undefined
[3] Russian Academy of Sciences,undefined
[4] Faculty of Biology and Biotechnology,undefined
[5] National Research University Higher School of Economics,undefined
来源
关键词
SARS-CoV-2; Omicron; HLA; peptide presentation; mutation; T-CoV;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:298 / 301
页数:3
相关论文
共 50 条
  • [1] Differences in Presentation of SARS-CoV-2 Omicron Strain Variant BA.1-BA.5 Peptides by HLA Molecules
    Nersisyan, S. A.
    Shkurnikov, M. Yu.
    Zhiyanov, A. P.
    Novosad, V. O.
    Tonevitsky, A. G.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2022, 507 (01) : 298 - 301
  • [2] Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5
    Tomokazu Tamura
    Daichi Yamasoba
    Yoshitaka Oda
    Jumpei Ito
    Tomoko Kamasaki
    Naganori Nao
    Rina Hashimoto
    Yoichiro Fujioka
    Rigel Suzuki
    Lei Wang
    Hayato Ito
    Yukie Kashima
    Izumi Kimura
    Mai Kishimoto
    Masumi Tsuda
    Hirofumi Sawa
    Kumiko Yoshimatsu
    Yuki Yamamoto
    Tetsuharu Nagamoto
    Jun Kanamune
    Yutaka Suzuki
    Yusuke Ohba
    Isao Yokota
    Keita Matsuno
    Kazuo Takayama
    Shinya Tanaka
    Kei Sato
    Takasuke Fukuhara
    Communications Biology, 6
  • [3] Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5
    Tamura, Tomokazu
    Yamasoba, Daichi
    Oda, Yoshitaka
    Ito, Jumpei
    Kamasaki, Tomoko
    Nao, Naganori
    Hashimoto, Rina
    Fujioka, Yoichiro
    Suzuki, Rigel
    Wang, Lei
    Ito, Hayato
    Kashima, Yukie
    Kimura, Izumi
    Kishimoto, Mai
    Tsuda, Masumi
    Sawa, Hirofumi
    Yoshimatsu, Kumiko
    Yamamoto, Yuki
    Nagamoto, Tetsuharu
    Kanamune, Jun
    Suzuki, Yutaka
    Ohba, Yusuke
    Tabata, Kaori
    Yokota, Isao
    Matsuno, Keita
    Takayama, Kazuo
    Tanaka, Shinya
    Sato, Kei
    Fukuhara, Takasuke
    COMMUNICATIONS BIOLOGY, 2023, 6 (01)
  • [4] In vitro activity of therapeutic antibodies against SARS-CoV-2 Omicron BA.1, BA.2 and BA.5
    Franck Touret
    Cécile Baronti
    Boris Pastorino
    Paola Mariela Saba Villarroel
    Laetitia Ninove
    Antoine Nougairède
    Xavier de Lamballerie
    Scientific Reports, 12
  • [5] In vitro activity of therapeutic antibodies against SARS-CoV-2 Omicron BA.1, BA.2 and BA.5
    Touret, Franck
    Baronti, Cecile
    Pastorino, Boris
    Villarroel, Paola Mariela Saba
    Ninove, Laetitia
    Nougairede, Antoine
    de Lamballerie, Xavier
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [6] Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission
    Shrestha, Lok Bahadur
    Foster, Charles
    Rawlinson, William
    Tedla, Nicodemus
    Bull, Rowena A.
    REVIEWS IN MEDICAL VIROLOGY, 2022, 32 (05)
  • [7] Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
    Tuekprakhon, Aekkachai
    Nutalai, Rungtiwa
    Dijokaite-Guraliuc, Aiste
    Zhou, Daming
    Ginn, Helen M.
    Selvaraj, Muneeswaran
    Liu, Chang
    Mentzer, Alexander J.
    Supasa, Piyada
    Duyvesteyn, Helen M. E.
    Das, Raksha
    Skelly, Donal
    Ritter, Thomas G.
    Amini, Ali
    Bibi, Sagida
    Adele, Sandra
    Johnson, Sile Ann
    Constantinides, Bede
    Webster, Hermione
    Temperton, Nigel
    Klenerman, Paul
    Barnes, Eleanor
    Dunachie, Susanna J.
    Crook, Derrick
    Pollard, Andrew J.
    Lambe, Teresa
    Goulder, Philip
    Paterson, Neil G.
    Williams, Mark A.
    Hall, David R.
    Fry, Elizabeth E.
    Huo, Jiandong
    Mongkolsapaya, Juthathip
    Ren, Jingshan
    Stuart, David, I
    Screaton, Gavin R.
    CELL, 2022, 185 (14) : 2422 - +
  • [8] The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5
    Shuai, Huiping
    Chan, Jasper Fuk-Woo
    Hu, Bingjie
    Chai, Yue
    Yoon, Chaemin
    Liu, Huan
    Liu, Yuanchen
    Shi, Jialu
    Zhu, Tianrenzheng
    Hu, Jing-Chu
    Hu, Ye-fan
    Hou, Yuxin
    Huang, Xiner
    Yuen, Terrence Tsz-Tai
    Wang, Yang
    Zhang, Jinjin
    Xia, Yao
    Chen, Lin-Lei
    Cai, Jian-Piao
    Zhang, Anna Jinxia
    Yuan, Shuofeng
    Zhou, Jie
    Zhang, Bao-Zhong
    Huang, Jian-Dong
    Yuen, Kwok-Yung
    To, Kelvin Kai-Wang
    Chu, Hin
    EBIOMEDICINE, 2023, 95
  • [9] Strong attenuation of SARS-CoV-2 Omicron BA.1 and increased replication of the BA.5 subvariant in human cardiomyocytes
    Nchioua, Rayhanel
    Diofano, Federica
    Noettger, Sabrina
    von Maltitz, Pascal
    Stenger, Steffen
    Zech, Fabian
    Muench, Jan
    Sparrer, Konstantin M. J.
    Just, Steffen
    Kirchhoff, Frank
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [10] Strong attenuation of SARS-CoV-2 Omicron BA.1 and increased replication of the BA.5 subvariant in human cardiomyocytes
    Rayhane Nchioua
    Federica Diofano
    Sabrina Noettger
    Pascal von Maltitz
    Steffen Stenger
    Fabian Zech
    Jan Münch
    Konstantin M. J. Sparrer
    Steffen Just
    Frank Kirchhoff
    Signal Transduction and Targeted Therapy, 7